Convertible Note - Decoy Therapeutics

Convertible Note - Decoy Therapeutics

Investment Firm

Overview

Decoy Therapeutics is a preclinical stage biotech company.

Announced Date

Apr 22, 2021

Funding Type

Convertible Note

Highlights

Location

United States, North America

Social

Investor Lead

Massachusetts Life Sciences Center

Massachusetts Life Sciences Center

Massachusetts Life Sciences Center is a debt and early_stage_venture and grant firm.

Participant Investors

1

Investor Name
Participant InvestorMassachusetts Life Sciences Center

Round Details and Background

Decoy Therapeutics raised $250000 on 2021-04-22 in Convertible Note

Decoy Therapeutics is a preclinical stage biotech company.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 22, 2021
Convertible Note - Decoy Therapeutics
1-250.0K

Recent Activity

There is no recent news or activity for this profile.